The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IkB Kinase and c-Jun N-Terminal Kinase


Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) (Apo2 ligand [Apo2L]) is a member of the TNF superfamily and has been shown to have selective antitumor activity. Although it is known that TRAIL (Apo2L) induces apoptosis and activates NF-kB and Jun N-terminal kinase (JNK) through receptors such as TRAIL-R1 (DR4) and TRAIL-R2 (DR5), the… (More)


7 Figures and Tables